pyridoxal phosphate and u 0126

pyridoxal phosphate has been researched along with u 0126 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Joshi, PG; Lakshmi, S	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1

Other Studies

2 other study(ies) available for pyridoxal phosphate and u 0126

Article	Year
Activation of Src/kinase/phospholipase C/mitogen-activated protein kinase and induction of neurite expression by ATP, independent of nerve growth factor. Neuroscience, 2006, Aug-11, Volume: 141, Issue:1 Topics: Adenosine; Adenosine Triphosphate; Animals; Butadienes; Cell Line, Tumor; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Immunohistochemistry; Mice; Microscopy, Confocal; Mitogen-Activated Protein Kinases; Neurites; Neuroblastoma; Nitriles; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y2; src-Family Kinases; Suramin; Type C Phospholipases	2006
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023

Article

Year

Activation of Src/kinase/phospholipase C/mitogen-activated protein kinase and induction of neurite expression by ATP, independent of nerve growth factor.

Neuroscience, 2006, Aug-11, Volume: 141, Issue:1

Topics: Adenosine; Adenosine Triphosphate; Animals; Butadienes; Cell Line, Tumor; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Immunohistochemistry; Mice; Microscopy, Confocal; Mitogen-Activated Protein Kinases; Neurites; Neuroblastoma; Nitriles; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y2; src-Family Kinases; Suramin; Type C Phospholipases

2006

In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.

Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023